GERRATANA, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 1.370
EU - Europa 1.338
AS - Asia 154
AF - Africa 12
SA - Sud America 8
OC - Oceania 3
Totale 2.885
Nazione #
US - Stati Uniti d'America 1.347
FR - Francia 978
IT - Italia 182
SE - Svezia 62
CN - Cina 55
VN - Vietnam 44
DE - Germania 43
CA - Canada 22
IN - India 16
RU - Federazione Russa 13
GB - Regno Unito 12
JP - Giappone 12
NL - Olanda 8
ZA - Sudafrica 7
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
CZ - Repubblica Ceca 5
PL - Polonia 5
UA - Ucraina 5
CL - Cile 4
DK - Danimarca 4
AU - Australia 3
BE - Belgio 3
EG - Egitto 3
IR - Iran 3
PT - Portogallo 3
SA - Arabia Saudita 3
BR - Brasile 2
IE - Irlanda 2
IL - Israele 2
KR - Corea 2
LB - Libano 2
TR - Turchia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BF - Burkina Faso 1
CH - Svizzera 1
CY - Cipro 1
FI - Finlandia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
KG - Kirghizistan 1
LT - Lituania 1
MA - Marocco 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
Totale 2.885
Città #
Fairfield 167
Ashburn 113
Woodbridge 100
Seattle 98
Houston 90
Santa Cruz 84
Buffalo 74
Stockholm 61
Wilmington 60
Cambridge 47
Udine 46
Dong Ket 44
Des Moines 32
Ann Arbor 30
Paris 30
Encino 22
Beijing 19
Chicago 19
Ottawa 15
Hangzhou 14
San Diego 14
Los Angeles 13
Clearwater 12
Gorizia 11
Las Vegas 10
Boardman 8
Milan 8
Mountain View 8
New York 8
Riva 8
Auburn 7
Muizenberg 7
Phoenix 7
Dallas 6
Fleming Island 6
Shenyang 6
Taipei 6
Tokyo 6
Topoľčany 6
Toronto 6
University Park 6
Bloomington 5
Montereale Valcellina 5
Rome 5
Trieste 5
Bangalore 4
Büdelsdorf 4
Council Bluffs 4
Palermo 4
Provo 4
Treppo Grande 4
Venice 4
Warsaw 4
Brooklyn 3
Brussels 3
Busto Arsizio 3
Giza 3
Gunzenhausen 3
Henderson 3
Jacksonville 3
London 3
Romans d'Isonzo 3
San Francisco 3
Scandale 3
Tappahannock 3
Watertown 3
Amsterdam 2
Azzano Decimo 2
Beirut 2
Copenhagen 2
Delhi 2
Dublin 2
Duncan 2
Falkenstein 2
Frankfurt Am Main 2
Kansas City 2
Lake Forest 2
Leatherhead 2
Lincoln 2
Moscow 2
Pacoima 2
Piscataway 2
Polcenigo 2
Reston 2
Rho 2
Rio De Janeiro 2
Risskov 2
San Jose 2
Sauris 2
Scafati 2
Scottsdale 2
Seoul 2
Settingiano 2
Shanghai 2
Stow 2
Utsunomiya 2
Venezia 2
Wuhan 2
Aidone 1
Alzate Brianza 1
Totale 1.491
Nome #
Circulating tumor cell clusters are frequently detected in women with early-stage breast cancer, file e27ce0c9-66af-055e-e053-6605fe0a7873 314
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation, file f9eadf0c-2240-4760-9366-592ddf9ad73d 246
Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review, file e27ce0c9-cf17-055e-e053-6605fe0a7873 235
Image Analysis of Circulating Tumor Cells and Leukocytes Predicts Survival and Metastatic Pattern in Breast Cancer Patients, file e27ce0c9-d3c4-055e-e053-6605fe0a7873 233
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer, file e27ce0c7-82d8-055e-e053-6605fe0a7873 168
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside, file e27ce0c6-accc-055e-e053-6605fe0a7873 156
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example, file e27ce0c3-2b61-055e-e053-6605fe0a7873 143
Luminal-like HER2-negative stage IA breast cancer: A multicenter retrospective study on long-term outcome with propensity score analysis, file e27ce0c4-fa92-055e-e053-6605fe0a7873 132
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC, file e27ce0c7-2b2a-055e-e053-6605fe0a7873 115
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study, file e27ce0c9-5222-055e-e053-6605fe0a7873 108
Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors, file e27ce0c6-78b5-055e-e053-6605fe0a7873 104
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer, file e27ce0c6-b570-055e-e053-6605fe0a7873 101
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC, file e27ce0c6-b3c3-055e-e053-6605fe0a7873 98
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients, file e27ce0c6-4748-055e-e053-6605fe0a7873 97
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer, file e27ce0c9-432f-055e-e053-6605fe0a7873 97
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA), file e27ce0c7-5355-055e-e053-6605fe0a7873 95
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer, file e27ce0c7-a1ae-055e-e053-6605fe0a7873 87
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition, file e27ce0c7-82d6-055e-e053-6605fe0a7873 81
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients, file e27ce0c7-7d6f-055e-e053-6605fe0a7873 77
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis, file e27ce0c8-839f-055e-e053-6605fe0a7873 75
Treatment of metastatic breast cancer in a real-world scenario: Is progression-free survival with first line predictive of benefit from second and later lines?, file e27ce0c3-31e8-055e-e053-6605fe0a7873 54
Landscape of circulating tumour DNA in metastatic breast cancer, file e27ce0c9-1dd7-055e-e053-6605fe0a7873 29
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis, file e27ce0c8-be18-055e-e053-6605fe0a7873 21
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer, file 0f67d732-f409-45d2-8b75-a37c19a6cdad 18
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure, file 5109e575-b118-4a31-9baf-0d795665211a 17
Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools, file e27ce0c8-e754-055e-e053-6605fe0a7873 12
Longitudinal dynamics of circulating tumor cells and circulating tumor DNA for treatment monitoring in metastatic breast cancer, file e27ce0c9-8575-055e-e053-6605fe0a7873 12
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer, file e27ce0c9-a8ed-055e-e053-6605fe0a7873 10
Liquid Biopsy, an Everchanging Balance between Clinical Utility and Emerging Technologies, file 7685dfb7-a47a-48f3-bfe7-6bd06d990a88 7
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer, file 364dafa3-b48e-459b-aa4a-acc5c39cd602 4
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer, file 86fd6d97-faac-41e0-9f24-e6a80b7807a2 3
Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis, file e27ce0c3-24c6-055e-e053-6605fe0a7873 3
Do platinum salts fit all triple negative breast cancers?, file e27ce0c3-15ec-055e-e053-6605fe0a7873 2
Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in Italy, file e27ce0c3-2895-055e-e053-6605fe0a7873 2
Pattern of metastasis and outcome in patients with breast cancer, file e27ce0c3-2c5e-055e-e053-6605fe0a7873 2
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis, file 517ccd8e-b9ba-47d5-a5ab-772e76fe1dc7 1
Measures of outcome in metastatic breast cancer: insights from a real-world scenario., file e27ce0c3-2c69-055e-e053-6605fe0a7873 1
Risk factors and survival outcomes in patients with brain metastases from breast cancer, file e27ce0c3-2efb-055e-e053-6605fe0a7873 1
Complementary and alternative medicine in oncology [Le terapie alternative e complementari in oncologia], file e27ce0c3-3071-055e-e053-6605fe0a7873 1
Factors affecting patient's perception of anticancer treatments side-effects: an observational study., file e27ce0c3-3404-055e-e053-6605fe0a7873 1
Determinants of Last-line Treatment in Metastatic Breast Cancer, file e27ce0c4-8da4-055e-e053-6605fe0a7873 1
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival, file e27ce0c8-87ed-055e-e053-6605fe0a7873 1
Neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios in breast cancer, file e27ce0c8-a0f0-055e-e053-6605fe0a7873 1
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use, file e27ce0c8-c49f-055e-e053-6605fe0a7873 1
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey, file e27ce0c8-c73f-055e-e053-6605fe0a7873 1
Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme, file e27ce0c9-411a-055e-e053-6605fe0a7873 1
Totale 2.969
Categoria #
all - tutte 4.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201975 0 0 0 0 0 0 0 3 7 14 28 23
2019/2020410 18 42 19 40 27 34 36 36 51 35 43 29
2020/2021430 24 30 35 49 38 51 26 25 33 34 29 56
2021/2022433 27 47 18 53 40 18 23 21 13 34 107 32
2022/2023391 10 21 90 44 27 67 11 21 38 15 33 14
2023/20241.180 22 21 46 24 48 130 20 869 0 0 0 0
Totale 2.969